Variant report
Variant | esv1808549 |
---|---|
Chromosome Location | chr8:65246984-65257503 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537075948 | chr8:65247009-65247010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186954865 | chr8:65247026-65247027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190510344 | chr8:65247044-65247045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545237304 | chr8:65247092-65247093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182415823 | chr8:65247144-65247145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187091614 | chr8:65247167-65247168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115168318 | chr8:65247168-65247169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561281041 | chr8:65247329-65247330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576008309 | chr8:65247351-65247352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35864490 | chr8:65247362-65247363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543821223 | chr8:65247369-65247370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10091651 | chr8:65247500-65247501 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs532650632 | chr8:65247514-65247515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547231871 | chr8:65247571-65247572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35421686 | chr8:65247607-65247608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559497978 | chr8:65247613-65247614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529958566 | chr8:65247636-65247637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544721918 | chr8:65247684-65247685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548486150 | chr8:65247696-65247697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569992792 | chr8:65247759-65247760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191805971 | chr8:65247779-65247780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552165927 | chr8:65247828-65247829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147294851 | chr8:65247866-65247867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534718565 | chr8:65247876-65247877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552839472 | chr8:65247908-65247909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572290421 | chr8:65247945-65247946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554664203 | chr8:65247999-65248000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536477707 | chr8:65248095-65248096 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140948240 | chr8:65248109-65248110 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143104949 | chr8:65248129-65248130 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182152319 | chr8:65248144-65248145 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187752823 | chr8:65248194-65248195 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376482074 | chr8:65248217-65248218 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7824601 | chr8:65248253-65248254 | Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs532483549 | chr8:65248269-65248270 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541509015 | chr8:65248274-65248275 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559918091 | chr8:65248275-65248276 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs193252098 | chr8:65248315-65248316 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529890185 | chr8:65248340-65248341 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545669791 | chr8:65248367-65248368 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548424311 | chr8:65248378-65248379 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563538390 | chr8:65248379-65248380 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs371589822 | chr8:65248387-65248388 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530834047 | chr8:65248402-65248403 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551838713 | chr8:65248407-65248408 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78682780 | chr8:65248408-65248409 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534361193 | chr8:65248418-65248419 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546653486 | chr8:65248424-65248425 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147493232 | chr8:65248438-65248439 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536415464 | chr8:65248466-65248467 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:65236400-65248000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:65248000-65249600 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:65248200-65248800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr8:65248200-65249000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr8:65249600-65260000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:65251400-65253800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr8:65253800-65254600 | Strong transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:65254200-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr8:65254400-65255600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr8:65254600-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr8:65254600-65257200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr8:65255200-65255400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr8:65257200-65257800 | Strong transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |